A novel fusion 5′AFF3/3′BCL2 originated from a t(2;18)(q11.2;q21.33) translocation in follicular lymphoma
暂无分享，去创建一个
M. Rocchi | C. L. Cunsolo | I. Panagopoulos | S. Funes | C. Storlazzi | F. Albano | L. Impera | F. Laveder | P. Iuzzolino
[1] Y. Hayashi,et al. Identification of the novel AML1 fusion partner gene, LAF4, a fusion partner of MLL, in childhood T-cell acute lymphoblastic leukemia with t(2;21)(q11;q22) by bubble PCR method for cDNA , 2008, Oncogene.
[2] M. Rocchi,et al. Upregulation of the SOX5 by promoter swapping with the P2RY8 gene in primary splenic follicular lymphoma , 2007, Leukemia.
[3] D. Arber,et al. ''Minor'' BCL2 breakpoints in follicular lymphoma: frequency and correlation with grade and disease presentation in 236 cases. , 2007, The Journal of molecular diagnostics : JMD.
[4] G. Bentley,et al. Variant t(14;18) in malignant lymphoma: a report of seven cases. , 2005, Cancer genetics and cytogenetics.
[5] P. Crilley,et al. Translocation (16;18)(p13;q21.3) in follicular lymphoma. , 2004, Cancer genetics and cytogenetics.
[6] Y. Hayashi,et al. Fusion of an AF4-related gene, LAF4, to MLL in childhood acute lymphoblastic leukemia with t(2;11)(q11;q23) , 2003, Oncogene.
[7] H. Ohno,et al. Heterogeneous Breakpoints on the Immunoglobulin Genes Are Involved in Fusion with the 5′ Region of BCL2 in B‐Cell Tumors , 2001, Japanese journal of cancer research : Gann.
[8] D. de Jong. Molecular pathogenesis of follicular lymphoma: a cross talk of genetic and immunologic factors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.